Tajana Filipec Kanižaj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tajana Filipec Kanižaj has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Helena Jerkić
Division of Cardiology, University Hospital Merkur
3 shared publications - Mladen Knotek
University Hospital Crosshouse, Kilmarnock, UK
2 shared publications - Tomislav Letilović
Merkur" University Hospital, Zagreb, Croatia
2 shared publications - Zrinka Sertić
Department of Internal Medicine, University Hospital Centre Zagreb, 10000 Zagreb, Croatia
2 shared publications - Damir Kozmar1 shared publication
- Darko Počanić1 shared publication
Latest Publications
- 1 September 2021
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 16 (9-10) , 289
Aortic balloon valvuloplasty as a bridge to liver transplantation in a patient with severe aortic stenosis and end-stage liver disease
- 1 September 2021
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 16 (9-10) , 289
Aortic balloon valvuloplasty as a bridge to liver transplantation in a patient with severe aortic stenosis and end-stage liver disease
- Open Access
- 21 May 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (20) , e26019
Cardiovascular mortality in liver and kidney transplant recipients
Previous studies have demonstrated cardiovascular causes to be among the leading causes of death after liver (LT) and kidney transplantation (KT). Although both recipient populations have unique pre-transplant cardiovascular burdens, they share similarities in post-transplant exposure to cardiovascular risk factors. The aim of this study was to compare cardiovascular mortality after LT and KT. We analyzed causes of death in 370 consecutive LT and 207 KT recipients from in-hospital records at a single tertiary transplant center. Cardiovascular causes of death were defined as cardiac arrest, heart failure, pulmonary embolism, or myocardial infarction. After a median follow-up of 36.5 months, infection was the most common cause of death in both cohorts, followed by cardiovascular causes in KT recipients and graft-related causes in LT recipients in whom cardiovascular causes were the third most common. Cumulative incidence curves for cardiovascular mortality computed with death from other causes as the competing risk were not significantly different (P = .36). While 1-year cumulative cardiovascular mortality was similar (1.6% after LT and 1.5% after KT), the estimated 4-year probability was higher post-KT (3.8% vs. 1.6%). Significant pre-transplant risk factors for overall mortality after KT in multivariable analysis were age at transplantation, left ventricular ejection fraction <50%, and diastolic dysfunction grade 2 or greater, while significant risk factors for cardiovascular mortality were peripheral artery disease and left ventricular ejection fraction <50%. In the LT group no variables remained significant in a multivariable model for either overall or cardiovascular mortality. The present study found no significant overall difference in cardiovascular mortality after LT and KT. While LT and KT recipients may have similar early cardiovascular mortality, long-term risk is potentially lower after LT. Differing characteristics of cardiovascular death between these two patient populations should be further investigated.
- 21 May 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (20) , e26019
Open AccessCardiovascular mortality in liver and kidney transplant recipients
Previous studies have demonstrated cardiovascular causes to be among the leading causes of death after liver (LT) and kidney transplantation (KT). Although both recipient populations have unique pre-transplant cardiovascular burdens, they share similarities in post-transplant exposure to cardiovascular risk factors. The aim of this study was to compare cardiovascular mortality after LT and KT. We analyzed causes of death in 370 consecutive LT and 207 KT recipients from in-hospital records at a single tertiary transplant center. Cardiovascular causes of death were defined as cardiac arrest, heart failure, pulmonary embolism, or myocardial infarction. After a median follow-up of 36.5 months, infection was the most common cause of death in both cohorts, followed by cardiovascular causes in KT recipients and graft-related causes in LT recipients in whom cardiovascular causes were the third most common. Cumulative incidence curves for cardiovascular mortality computed with death from other causes as the competing risk were not significantly different (P = .36). While 1-year cumulative cardiovascular mortality was similar (1.6% after LT and 1.5% after KT), the estimated 4-year probability was higher post-KT (3.8% vs. 1.6%). Significant pre-transplant risk factors for overall mortality after KT in multivariable analysis were age at transplantation, left ventricular ejection fraction <50%, and diastolic dysfunction grade 2 or greater, while significant risk factors for cardiovascular mortality were peripheral artery disease and left ventricular ejection fraction <50%. In the LT group no variables remained significant in a multivariable model for either overall or cardiovascular mortality. The present study found no significant overall difference in cardiovascular mortality after LT and KT. While LT and KT recipients may have similar early cardiovascular mortality, long-term risk is potentially lower after LT. Differing characteristics of cardiovascular death between these two patient populations should be further investigated.
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 315
Cardiovascular risk profile and adverse events in renal and liver transplant recipients
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 315
Cardiovascular risk profile and adverse events in renal and liver transplant recipients